ArticleImmunoTargets and therapy2025
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer.
Carole Seguin-Devaux et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it